BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moon SJ, Lee SH, Byun YH, Yun GY, Kim SK, Seong BL, Kim AR, Sun Park E, Kim HJ, Lee JE, Ha SK, Lee JM, Park HC. Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients. BMC Nephrol 2012;13:165. [PMID: 23206898 DOI: 10.1186/1471-2369-13-165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Gilbertson DT, Wetmore JB. Infections Requiring Hospitalization in Patients on Hemodialysis. Clin J Am Soc Nephrol 2015;10:2101-3. [PMID: 26567371 DOI: 10.2215/CJN.10891015] [Reference Citation Analysis]
2 Pawlowski B, Borkowska B, Nowak J, Augustyniak D, Drulis-kawa Z. Human body symmetry and immune efficacy in healthy adults: PAWLOWSKI et al . Am J Phys Anthropol 2018;167:207-16. [DOI: 10.1002/ajpa.23617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Longlune N, Nogier MB, Miedougé M, Gabilan C, Cartou C, Seigneuric B, Del Bello A, Marion O, Faguer S, Izopet J, Kamar N. High immunogenicity of a messenger RNA based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant 2021:gfab193. [PMID: 34057463 DOI: 10.1093/ndt/gfab193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
4 Pawłowski B, Nowak J, Borkowska B, Augustyniak D, Drulis-Kawa Z. Body height and immune efficacy: testing body stature as a signal of biological quality. Proc Biol Sci 2017;284:20171372. [PMID: 28724741 DOI: 10.1098/rspb.2017.1372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
5 Wyatt L, Permar SR, Ortiz E, Berky A, Woods CW, Amouou GF, Itell H, Hsu-Kim H, Pan W. Mercury Exposure and Poor Nutritional Status Reduce Response to Six Expanded Program on Immunization Vaccines in Children: An Observational Cohort Study of Communities Affected by Gold Mining in the Peruvian Amazon. Int J Environ Res Public Health 2019;16:E638. [PMID: 30795575 DOI: 10.3390/ijerph16040638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Cloots K, Burza S, Malaviya P, Hasker E, Kansal S, Mollett G, Chakravarty J, Roy N, Lal BK, Rijal S, Sundar S, Boelaert M. Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data. PLoS Negl Trop Dis 2020;14:e0007995. [PMID: 31995564 DOI: 10.1371/journal.pntd.0007995] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
7 Esposito S, Mastrolia MV, Ghio L, Paglialonga F, Terranova L, Scala A, Edefonti A, Principi N. Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults. Expert Review of Vaccines 2014;13:1059-66. [DOI: 10.1586/14760584.2014.935768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
8 Manley HJ, Lacson EK, Aweh G, Li NC, Weiner DE, Miskulin DC, Hsu CM, Kapoian T, Hayney MS, Meyer KB, Johnson DS. Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients. American Journal of Kidney Diseases 2022. [DOI: 10.1053/j.ajkd.2022.01.425] [Reference Citation Analysis]
9 Nowak J, Pawłowski B, Borkowska B, Augustyniak D, Drulis-Kawa Z. No evidence for the immunocompetence handicap hypothesis in male humans. Sci Rep 2018;8:7392. [PMID: 29743556 DOI: 10.1038/s41598-018-25694-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
10 Grzegorzewska AE. Prophylactic vaccinations in chronic kidney disease: Current status. Hum Vaccin Immunother 2015;11:2599-605. [PMID: 25911956 DOI: 10.1080/21645515.2015.1034915] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
11 Boedecker-Lips SC, Lautem A, Runkel S, Klimpke P, Kraus D, Keil P, Holtz S, Tomalla V, Marczynski P, Boedecker CB, Galle PR, Koch M, Weinmann-Menke J. Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients. Pathogens 2022;11:67. [PMID: 35056015 DOI: 10.3390/pathogens11010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Cheng CY, Fang TC, Liao HW, Chen TH, Chang JH, Lin YC, Kao CC, Liu MC, Chang HW, Hung CS, Wang JC, Hsiao SH, Sue YM. The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection. Vaccines (Basel) 2022;10:338. [PMID: 35214797 DOI: 10.3390/vaccines10020338] [Reference Citation Analysis]
13 Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB. Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. J Am Soc Nephrol 2019;30:346-53. [PMID: 30679380 DOI: 10.1681/ASN.2018060581] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
14 Shim DH, Kim MJ, Cha HR, Park ES, Kim AR, Park JH, Park HC, Song D, Lee JM. Development of a HA1-specific enzyme-linked immunosorbent assay against pandemic influenza virus A H1N1. Clin Exp Vaccine Res 2019;8:70-6. [PMID: 30775353 DOI: 10.7774/cevr.2019.8.1.70] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Principi N, Esposito S. Influenza vaccination in patients with end-stage renal disease. Expert Opinion on Drug Safety 2015;14:1249-58. [DOI: 10.1517/14740338.2015.1053459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
16 Ganczak M, Dubiel P, Drozd-Dąbrowska M, Hallmann-Szelińska E, Szymański K, Brydak LB. Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season. Int J Environ Res Public Health 2019;16:E4489. [PMID: 31739554 DOI: 10.3390/ijerph16224489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Miskulin DC, Weiner DE, Tighiouart H, Lacson EK Jr, Meyer KB, Dad T, Manley HJ. High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis. Clin J Am Soc Nephrol 2018;13:1703-11. [PMID: 30352787 DOI: 10.2215/CJN.03390318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]